Template:Metoprolol: Difference between revisions

Jump to navigation Jump to search
No edit summary
mNo edit summary
Line 2: Line 2:
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Metoprolol|{{fontcolor|#6C7B8B|Metoprolol}}]]'''''
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Metoprolol|{{fontcolor|#6C7B8B|Metoprolol}}]]'''''
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Lopressor<sup>®</sup>, Toprol XL<sup>®</sup> FDA Package Insert
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Lopressor<sup>®</sup> FDA Package Insert
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol indications and usage|Indications and Usage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol indications and usage|Indications and Usage]]
Line 33: Line 33:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol labels and packages|Labels and Packages]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol labels and packages|Labels and Packages]]
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Metoprolol
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
|-
|-
|}
|}

Revision as of 02:43, 9 February 2014